Search Results 1111-1120 of 17880 for monoclonal antibody
Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or who has not recovered (i.e., ≤ Grade 1 or at baseline) from ...
... resistant prostate cancer (mCRPC) · Monoclonal antibody medicines for cancer: How they work · Multiple myeloma · Myxofibrosarcoma · Neuroblastoma · No appetite?
Prior severe infusion reaction to a monoclonal antibody. Severe, active co-morbidity, defined as follows: Significant history of uncontrolled cardiac ...
Pertuzumab, an anti-HER2 humanized monoclonal antibody ... In this respect, anti-ErbB2 monoclonal antibody 4D5 specifically inhibits the growth of tumor cells ...
The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...
At present, of the 30-plus antibodies the neuroimmunology lab has tests for, more than five are only available at Mayo Clinic Laboratories because they are new ...
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a ... monoclonal antibody with the exception of blinatumomab; patients must have ...
≥ 200 mg/24 hours of monoclonal protein on a 24-hour urine protein electrophoresis. ... Monoclonal bone marrow plasmacytosis ≥ 30% (evaluable disease).
2 cycles of an anti-CD20 monoclonal antibody (unless investigator determines that tumor is CD20 negative) and anthracycline-containing regimen (e.g., DA ...
... Monoclonal Antibody, RUO). Exclusion Criteria: The amount of tumor tissue is insufficient to cut and mount the required number of tissue sections for use in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!